IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I4A84

Novel indication for bioabsorbable scaffolds in metal allergy

Niket Patel*, MBBS, BSc, MRCP; Anthony Mechery, MBBS, MD, DM, MRCP; George Kassimis, MD, PhD; Adrian P. Banning, MBBS, MD, FRCP; Rajesh Kharbanda, MBChB, PhD, MRCP

A 74-year-old female with exertional breathlessness and a metal allergy underwent angiography following positive stress echocardiography. This demonstrated severe calcific disease of the left anterior descending artery (LAD) (Figure 1A). Percutaneous intervention (PCI) was offered after the failure of medical therapy.

Figure 1. A) Calcified mid-LAD lesion. B) Unsuccessful predilation (significant wasting). C) Post-rotablation lesion expansion. D) Result following two overlapping Abbott BVS.

Patch testing confirmed allergy to nickel and cobalt. Most stent platforms contain alloys that include nickel (Table 1), which may contribute to restenosis in this context.

Balloon predilation was unsuccessful (Figure 1B). Therefore, rotablation with a 1.5 mm burr (Boston Scientific, Natick, MA, USA) was performed. After further predilation (Figure 1C) and QCA, overlapping 3×28 mm and 3.5×28 mm ABSORB Revision 1.1 bioabsorbable scaffolds (BVS) (Abbott Vascular, Santa Clara, CA, USA) (Figure 1C) were implanted. Postdilation with a non-compliant 3.25 mm balloon was performed (Figure 1D). The patient was symptom free at six-month review.

Although nickel allergy is not a conventional contraindication to stenting, bioabsorbable scaffolds such as the poly-L-lactide Abbott BVS now provide an alternative interventional strategy to metallic stents in this situation. Additionally, this case exemplifies the use of this technology in complex lesions.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 10 Number 4
Aug 19, 2014
Volume 10 Number 4
View full issue


Key metrics

On the same subject

Reply to the letter to the editor

10.4244/EIJ-D-23-00985 Feb 19, 2024
Reply: The ROTA-CUT randomised trial: push the button harder
Sharma S et al

Research Correspondence

10.4244/EIJ-D-23-00743 Feb 19, 2024
Final report of the PROTEMBO C Trial: a prospective evaluation of a novel cerebral protection device during TAVI
Fezzi S et al

Editorial

10.4244/EIJ-E-23-00071 Feb 19, 2024
One-year outcomes with a new mitral edge-to-edge repair device: is mitral TEER about to conquer the world?
Praz F and Samim D
free

Editorial

10.4244/EIJ-E-24-00003 Feb 19, 2024
Between Scylla and Charybdis in atrial functional mitral regurgitation
Denti P
free

Letter to the editor

10.4244/EIJ-D-23-00937 Feb 19, 2024
Letter: The ROTA-CUT randomised trial: push the button harder
Novelli L et al

Original Research

10.4244/EIJ-D-23-00819 Feb 19, 2024
Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation
Tanaka T et al

Expert Review

10.4244/EIJ-D-23-00700 Feb 19, 2024
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy M and Maisano F
free
Trending articles
128.23

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
108.5

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
99.18

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
76.13

State of the art

10.4244/EIJ-D-22-00969 Jun 19, 2023
Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation
Faria D et al
free
48.85

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved